(Q24246371)

4

object named as

Eduardo Nobile-Orazio

0 references

author name string

David Allen

1

0 references

Michael PT Lunn

2

0 references

JikkeMien Niermeijer

Cochrane Database of Systematic Reviews

3

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

IgG monoclonal paraproteinaemia and peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Chronic inflammatory demyelinating polyradiculoneuropathy: Comparison of patients with and without an associated monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Axonal neuropathy associated with monoclonal gammopathy of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Neuropathy associated with monoclonal gammopathies of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Connecting impairment, disability, and handicap in immune mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Monoclonal gammopathies in the adult population of Finistère, France

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Clinical spectrum of chronic acquired demyelinating polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

IgG monoclonal proteins from patients with axonal peripheral neuropathies bind to different epitopes of the 68 kDa neurofilament protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

Myelin widenings and MGUS-IgA: An immunoelectron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Comparison between impairment and disability scales in immune-mediated polyneuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Risk factors for hematological malignancy in polyneuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

"Benign" monoclonal gammopathy--after 20 to 35 years of follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Benign monoclonal IgAK gammopathy associated with polyneuropathy and dysautonomia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Prevalence of monoclonal protein in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021

Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005376.PUB2

7 January 2021